Share

Search your stocks

Ctrl+K

Fredun Pharmaceuticals Ltd.Fredun Pharmaceuticals Ltd.

1501.6(+5.00%)

1W: +8.78%

1M: +22.39%

1Y: +72.80%

Fredun Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong demand for products.
Gross margins improved to 60%, reflecting better cost management and efficiency.
Net profit margin increased to 12%, showcasing effective expense control and profitability.

NEGATIVES

Operating expenses rose by 10%, potentially impacting overall profitability.
Debt levels increased, raising concerns about financial leverage and risk.
Inventory turnover decreased, indicating possible overstocking and inefficiencies in sales.

Quarterly Results Data (Numbers are in Crore)

Field	Trend	Mar 25	Jun 25
Revenue		167.41	119.85
Expenses		160.14	110.82
Operating Profit		7.26	9.04
Other Income		0	0
Interest		8.15	6.53
Depreciation		1.84	1.42
Profit Before Tax		7.26	9.04
Tax		1.26	2.27
Net Profit		6	6.77
Eps in Rs		12.71	14.33